Corevitas Thermo Fisher Deal: CorEvitas data intelligence platform would be added to Thermo Fisher s laboratory products and biopharma services unit, upon completion of the deal.
:Thermo Fisher Scientific said on Thursday it would acquire healthcare data provider CorEvitas for $912.5 million in cash, as the medical products maker looks to boost its portfolio of services offered to pharmaceutical clients.Thermo Fisher has been on an acquisition spree in recent years as it strives to be
Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.